Biotechnology Jobs

• Waltham, United States
• Hybrid · 2–3 days in office
• US$222,750 – US$371,250 pa
• Director

Serves as the physician on a clinical programme team, leading medical monitoring and safety oversight for GI oncology studies. Interprets clinical and safety data, contributes to protocol development, and engages investigators and regulators. Works within a Clinical Matrix Team alongside Clinical Operations, Biostatistics, Regulatory and Pharmacovigilance, with on-site presence 2-3 days a week.

AI

• Stevenage
• On-site
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within an oncology clinical programme team, leading medical monitoring, safety oversight and clinical data interpretation for GI studies. Partners with a Senior Scientist and cross-functional matrix teams on protocol development, regulatory interactions and investigator engagement. Requires on-site presence 2-3 days a week, with the Stevenage base relocating to Cambridge, UK by early 2029.

AI

• London
• Hybrid
• US$188,100 – US$313,500 pa
• Director
• Permanent

Leads quantitative systems pharmacology and QST modelling within a clinical pharmacology and quantitative medicine group, building mechanistic models of disease and drug action and running simulations to inform trial design. Defines and coordinates MIDD strategies across respiratory, immunology and inflammation programmes, working with biologists, clinicians, pharmacometricians and AI/ML specialists. The role sits in a newly formed centre of excellence and involves representing QSP on internal advisory boards.

• Durham Blackwell Street
• US$188,100 – US$313,500 pa
• Director

Leads quantitative systems pharmacology and QST modelling within a clinical pharmacology and quantitative medicine group, building mechanistic models of disease and drug action and running simulations to assess trial design. Defines and coordinates MIDD strategies across respiratory, immunology and inflammation programmes, working with biologists, clinicians, pharmacometricians and AI/ML specialists. The role sits in a newly established Centre of Excellence for model-informed drug development.

• London
• Hybrid · 2 days in office
• US$340,500 – US$567,500 pa
• Senior · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability and chairing a cross-functional matrix Medicine Development Team spanning clinical, translational, regulatory, manufacturing and commercial. Drives strategy, go/no-go decisions and lifecycle plans for novel vaccine platforms such as mRNA and neoantigen-based therapies.

mRNA · Checkpoint Inhibitors

• Waltham, United States
• Hybrid · 2 days in office
• US$340,500 – US$567,500 pa
• Director · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and represents the asset to senior governance boards.

mRNA · Personalized Vaccine Manufacturing · Checkpoint Inhibitors

• Stevenage
• Hybrid · 2 days in office
• US$340,500 – US$567,500 pa
• Director · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and leads a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and sets the asset strategy within GSK's oncology R&D portfolio.

mRNA · Checkpoint Inhibitors

• Zug, Switzerland
• Hybrid · 2 days in office
• US$340,500 – US$567,500 pa
• Director · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and serves as asset spokesperson to senior governance boards.

mRNA · Checkpoint Inhibitors

• London
• Hybrid · 2–3 days in office
• Director

Develops and executes global and regional regulatory strategies for assigned assets in the Respiratory, Immunology & Inflammation therapeutic group, managing regulatory interactions, submissions and review processes across regions. Ensures compliance with internal GSK processes and regulatory requirements to secure optimal labelling, working closely with global counterparts and commercial teams.

AI

• Durham, United States
• Lead

Lead authoring and strategic planning for clinical and regulatory documents, including protocols, clinical study reports, briefing documents and submission dossiers. Manages end-to-end writing projects, coordinating contributors, timelines and quality checks, and acts as subject matter expert on medical writing standards, CTD structure and regulatory expectations while driving process improvement and audit readiness.

• London
• Lead

Lead authoring and strategic planning of clinical and regulatory documents such as protocols, clinical study reports, briefing documents and CTD submission dossiers. Manage end-to-end writing projects, coordinating contributors, timelines and quality checks, and act as subject matter expert on medical writing standards and regulatory expectations while driving process improvement and audit readiness.

• Upper Providence
• Hybrid · 2 days in office
• US$340,500 – US$567,500 pa
• Director · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and leads a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and drives strategy, go/no-go decisions and lifecycle planning.

mRNA · Checkpoint Inhibitors

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• US$340,500 – US$567,500 pa
• Director · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and drives strategy, go/no-go decisions and lifecycle planning.

mRNA · Checkpoint Inhibitors

• Rockville, United States
• Hybrid · 2–3 days in office
• £221,925 – £369,875 pa
• Director · manages people

Leads a global oncology labelling team, managing the labelling process from early development through lifecycle management and ensuring regulatory compliance. Serves on the Global Labelling Committee, advises senior R&D, Safety, Regulatory and Commercial leaders, and engages with regulatory authorities on labelling standards and policy.

• Belgium-Wavre
• Hybrid · 2–3 days in office
• €89,250 – €231,000 pa
• Director

Develops and executes global and regional regulatory strategies for assigned assets in respiratory, immunology and inflammation, managing regulatory interactions, submissions and review processes across major markets. Ensures compliance with internal policies and regulatory requirements to deliver optimal labelling, working closely with global, regional and commercial teams. Hybrid role with mandatory on-site collaboration two to three days per week.

AI